4
Changes in Ownership
Gain Therapeutics, Inc. Filed Acc 0001209191-22-042572
Options or other derivatives
- Chief Financial Officer acquired 69,300 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Calabrese Salvatore Chief Financial Officer | 2022-07-15 | Grant or award · Employee Stock Option (right to buy) | +59,400 | 59,400 | D | ||
| Calabrese Salvatore Chief Financial Officer | 2022-07-15 | Grant or award · Restricted Stock Units | +9,900 | 9,900 | D | ||
Loading xslF345X03/doc4.xml…